Edition:
India

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349.HK)

1349.HK on Hong Kong Stock

4.02HKD
7:14am IST
Change (% chg)

HK$-0.04 (-0.99%)
Prev Close
HK$4.06
Open
HK$4.06
Day's High
HK$4.06
Day's Low
HK$4.01
Volume
54,000
Avg. Vol
845,852
52-wk High
HK$6.80
52-wk Low
HK$3.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 272.04 0.054
FY 2016 Dec '16 379.96 0.101
Jun '16 241.91 0.050
FY 2015 Dec '15 365.24 0.095
Jun '15 214.22 0.043
 
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-17 1 850.59 850.59 850.59 1,100.07
Year Ending Dec-18 1 985.94 985.94 985.94 1,405.33
Earnings (per share)
Year Ending Dec-17 2 0.20 0.21 0.20 0.26
Year Ending Dec-18 2 0.24 0.25 0.23 0.36
LT Growth Rate (%) 1 25.41 25.41 25.41 39.65
Sales and Profit Figures in Hong Kong Dollar (HKD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 22.26 31.14 32.93
P/E High - Last 5 Yrs. 50.49 40.91 45.62
P/E Low - Last 5 Yrs. 24.70 23.80 24.34
Beta 0.81 0.90 0.88
Price to Sales (TTM) 4.86 3.93 5.40
Price to Book (MRQ) 3.74 4.81 5.38
Price to Tangible Book (MRQ) 3.84 5.53 6.78
Price to Cash Flow (TTM) 18.57 23.04 23.45
% Owned Institutions -- 0.88 1.40

Dividends

  Company industry sector
Dividend Yield 1.42 1.56 1.50
Dividend Yield - 5 Year Avg 0.53 1.57 1.52
Dividend 5 Year Growth Rate -- 4.33 5.17
Payout Ratio(TTM) 32.42 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 12.46 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago 7.39 4.66 5.38
Sales - 5 Yr. Growth Rate 35.95 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 7.92 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago 6.23 -- --
EPS - 5 Yr. Growth Rate 28.19 9.86 10.79
Capital Spending - 5 Yr. Growth Rate 8.48 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.42 2.11 2.18
Current Ratio (MRQ) 2.54 2.88 2.98
LT Debt to Equity (MRQ) 0.00 9.47 11.56
Total Debt to Equity (MRQ) 18.89 13.43 15.81
Interest Coverage (TTM) -- 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 92.23 55.14 54.83
Gross Margin - 5 Yr. Avg. 91.84 52.29 52.40
EBITD Margin (TTM) 28.26 -- --
EBITD - 5 Yr. Avg 29.54 18.46 15.24
Operating Margin (TTM) 24.43 14.50 7.76
Operating Margin - 5 Yr. Avg. 26.30 14.42 10.75
Pre-Tax Margin (TTM) 23.70 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. 25.06 14.74 11.17
Net Profit Margin (TTM) 20.55 11.22 4.88
Net Profit Margin - 5 Yr. Avg. 21.70 11.08 7.47
Effective Tax Rate (TTM) 13.26 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. 13.41 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 1,264,965 953,213,828 864,673,362
Net Income/Employee (TTM) 260,010 112,151,383 101,717,513
Receivable Turnover (TTM) 6.74 5.60 5.76
Inventory Turnover (TTM) 1.87 2.58 3.34
Asset Turnover (TTM) 0.59 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 12.18 11.42 11.00
Return on Assets - 5 Yr. Avg. 13.01 13.00 12.43
Return on Investment (TTM) 16.44 14.86 14.46
Return on Investment - 5 Yr. Avg. 17.67 17.00 16.28
Return on Equity (TTM) 17.82 16.28 16.05
Return on Equity - 5 Yr. Avg. 19.84 18.03 17.51
  1 Year 3 Year 5 Year
Sales % 7.32 14.35 35.95
EPS (TTM) % 8.60 14.20 28.19
Dividend % 66.67 -- --
Note: Units in Millions of US Dollars

Performance for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.85%
# of Holders: 23
Total Shares Held: 19,897,090
3 Mo. Net Change: 2,708
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 4
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.